Hrt Financial LP Exact Sciences Corp Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Hrt Financial LP holds 64,952 shares of EXAS stock, worth $3.75 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

64,952

Holding current value

$3.75 Million

% of portfolio

0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$42.43 - $70.83 $2.76 Million - $4.6 Million	64,952 New	64,952 $4.42 Million
Q1 2024 May 13, 2024	BUY	$56.27 - $73.77 $4.08 Million - $5.35 Million	72,462 Added 1519.12%	77,232 $5.33 Million
Q4 2023 Feb 09, 2024	SELL	$59.06 - $75.72 $477,204 - $611,817	-8,080 Reduced 62.88%	4,770 $352,000
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $847,329 - $1.27 Million	12,850 New	12,850 $876,000
Q1 2023 May 12, 2023	SELL	$47.19 - $70.77 $4.31 Million - $6.46 Million	-91,338 Reduced 92.54%	7,362 $499,000
Q4 2022 Feb 10, 2023	BUY	$30.35 - $53.15 $3 Million - $5.25 Million	98,700 New	98,700 $4.89 Million
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $3.85 Million - $5.34 Million	-53,085 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $4.79 Million - $6.59 Million	53,085 New	53,085 $5.07 Million
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $1.31 Million - $1.95 Million	-14,010 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $1.63 Million - $2.17 Million	14,010 New	14,010 $1.85 Million
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $404,615 - $577,291	-4,062 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $436,863 - $611,141	-5,991 Reduced 59.59%	4,062 $414,000
Q2 2018 Aug 15, 2018	BUY	$37.84 - $69.96 $380,405 - $703,307	10,053 New	10,053 $601,000

Others Institutions Holding EXAS

# of Institutions

676

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account